A practical reference on growth hormone secretagogue: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-10-18 and is reviewed periodically as new material appears.
In the scientific literature, ipamorelin appears mainly in preclinical studies, receptor binding assays, and reviews of growth hormone secretagogues. Authors often discuss its selectivity profile alongside limitations such as small sample sizes, short study durations, and differences between species. Some papers examine pharmacokinetics and clearance, but human data are limited and not sufficient to define general clinical effects. Regulatory discussion treats the compound as an investigational or research substance rather than an approved therapy in most jurisdictions. Open questions include oral bioavailability, long-term endocrine effects, and whether selectivity observed in animals persists in humans.
Research peptides such as ipamorelin are commonly supplied as lyophilized powder and characterized by analytical certificates. Reversed-phase high-performance liquid chromatography is used to estimate purity by ultraviolet absorbance, while mass spectrometry confirms molecular identity and detects sequence-related impurities. Counterion content, water content, and residual synthesis reagents can affect the reported mass balance. A certificate of analysis may list a purity percentage, but that number depends on the analytical method and the definition of impurity peaks. Independent verification is often recommended because research supply chains vary in quality control practices.
Storage recommendations for ipamorelin usually focus on temperature, moisture, and light. Lyophilized powder is typically held at or below minus twenty degrees Celsius in a desiccated container protected from light. Reconstituted solutions are often aliquoted and stored at minus eighty degrees Celsius to reduce repeated freeze-thaw cycles, which can promote aggregation or degradation. The optimal buffer and pH depend on the specific assay, and no single condition applies to every experimental context. Peptide stability should be assessed with time-point measurements rather than assumed from general handling rules.
At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor type 1a, the same G protein-coupled receptor that binds ghrelin. Receptor activation couples to Gq/11 signaling, raising intracellular calcium through inositol trisphosphate and diacylglycerol, which in turn promotes exocytosis of growth hormone from pituitary somatotroph cells. Ipamorelin binds this receptor with high affinity and shows weak activity at other secretagogue-related targets in vitro. Its action requires the intact receptor and is not reversed by growth hormone-releasing hormone antagonists.
Compared with earlier growth hormone secretagogues such as GHRP-6 and hexarelin, ipamorelin has been reported to produce less stimulation of adrenocorticotropic hormone, cortisol, and prolactin in animal and early human studies. This selectivity is usually attributed to differences in receptor subtype interactions and to the tissue distribution of the receptor. Effects on appetite appear weaker than those of ghrelin itself, although the supporting evidence base is small. Whether these differences produce a distinct clinical profile remains an open question, since controlled human trials are limited.
Ipamorelin is a synthetic pentapeptide first described in the 1990s by researchers at Novo Nordisk during a program to develop selective growth hormone secretagogues. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, incorporating two non-natural residues, alpha-aminoisobutyric acid and D-2-naphthylalanine. The C-terminus is amidated, and the material is supplied as a white lyophilized powder. The molecular formula is C38H49N9O5 and the monoisotopic mass is approximately 711.85 daltons. The short chain and modified residues give it greater resistance to enzymatic degradation than many larger peptide hormones.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized solid |
| Solubility class | Soluble in water and aqueous buffers | Solubility can depend on pH and salt form |
| Typical storage temperature | −20 °C or lower, desiccated | Protect from light and moisture |
| Typical analytical method | RP-HPLC with UV detection; LC-MS | Identity and purity assessment |
| Common salt form | Acetate salt | Frequently used in research supply |
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue class. It acts as an agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor type 1a. The compound was designed in the 1990s during a search for agents that release growth hormone with fewer off-target hormonal effects than earlier secretagogues. It appears in the research literature under several sequence-based names. Material supplied for laboratory work is normally a lyophilized solid, and it is not marketed as an approved therapeutic in major jurisdictions.
The molecule contains five residues, including alpha-aminoisobutyric acid, D-2-naphthylalanine, and D-phenylalanine, and it ends in a lysine amide. Non-natural and D-configured residues make the chain less susceptible to common peptidases, which helps explain its resistance to rapid breakdown. Its molecular formula is C38H49N9O5, corresponding to a free-base mass near 711.9 daltons. The C-terminal amide removes a negative charge and is a recurring feature in receptor-active peptides of this family. These structural choices are usually discussed as the basis for its selectivity profile.
在 GHS 家族中，早期肽类如 GHRP-6 与 GHRP-2 会同时促进生长激素、皮质醇与催乳素的释放，并明显增加食欲。Ipamorelin 在动物与早期人体研究中表现出对生长激素释放的相对选择性，对上述其他激素的影响较小。这种差异通常归因于受体结合模式与下游信号偏向的不同，而完整的分子解释仍有待补充。需要区分的是，选择性是研究观察中的相对程度，并非绝对界限。
从用途定位看，ipamorelin 目前主要以研究用肽的身份被讨论，未见主要药品监管机构将其批准为治疗药物。市售材料通常标注仅供研究使用，不得用于人体或诊断程序。文献中它常与生长激素促分泌素、GHS-R1a 激动剂、胃饥饿素拟似物等表述并列出现。既有研究的样本量普遍偏小，因此对其效应强度与一致性的描述应保持谨慎。
Selectivity is the property most often attached to this peptide. Published animal and early human studies record increases in growth hormone release after administration, with adrenocorticotropic hormone and cortisol responses remaining small by comparison. Effects on appetite-related pathways also appear weaker than those reported for several earlier secretagogues. Reviews that compare members of the growth hormone secretagogue family cite these findings frequently, though the receptor-level explanation for the selectivity continues to be debated rather than settled.
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. Its sequence, Aib-His-D-2-Nal-D-Phe-Lys-NH2, combines three non-proteinogenic residues with a C-terminal amide. The N-terminal aminoisobutyric acid unit and the two aromatic D-amino acids distinguish it from peptides assembled only from standard L-amino acids. Its formula is C38H49N9O5, corresponding to an average mass near 711.9 Da. At neutral pH the molecule carries a net positive charge, a property that shapes its behaviour in chromatographic and electrophoretic systems.
Structural features distinguish the molecule from earlier secretagogues. An alpha-aminoisobutyric acid residue near the N-terminus and a D-naphthylalanine substitution increase receptor affinity, while C-terminal amidation improves resistance to exopeptidases. These modifications are associated with reduced stimulation of appetite and of the hypothalamic-pituitary-adrenal axis compared with hexarelin or growth hormone releasing peptide-6. Whether the same profile applies at every dose level studied is a matter of ongoing investigation rather than settled consensus.
Ipamorelin is a synthetic pentapeptide that acts as an agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor type 1a. Its sequence incorporates non-natural residues, which slows enzymatic breakdown relative to short native peptides. In laboratory and early clinical work the compound is described as a selective growth hormone secretagogue because it raises growth hormone with comparatively little effect on other pituitary outputs. The degree to which that selectivity holds across species and dosing regimens remains an open question in the published literature.
=== Safety of radiolabeled somatostatin receptor antagonists === In general, somatostatin receptor antagonists were noted to be well tolerated. However, due to its mechanism of action, it may decrease the effectiveness of SSA therapy (Somatostatin Analogue Therapy), but other studies indicate SSA may not need to be stopped if somatostatin antagonists are used to for tumor labelling instead of agonists. As somatostatin can cause inhibition of hormone production that uses it as a mediating hormone, it has an antiproliferative effect on cell tumors, especially in neuroendocrine tumors. Somatostatin analogue therapy uses longer-acting agonists than the endogenous somatostatin to extend the antiproliferative effects. Somatostatin receptor antagonists can bind to the receptors without activating them, antagonizing the therapeutic inhibitory effects of SSA therapy. Slow intravenous injection might be used until further safety data become available.
The US and the USSR sent animals into space to determine the safety of the environment before sending the first humans. The USSR used dogs for this purpose, and the US used monkeys and apes. The first mammal in space was Albert II, a rhesus monkey launched by the US on a sub-orbital flight on June 14, 1949, who died on landing due to a parachute malfunction. The USSR sent the dog Laika into orbit on Sputnik 2, the second satellite launched, on November 3, 1957, for an intended ten-day flight. They did not yet have the technology to return Laika safely to Earth, and the government reported Laika died when the oxygen ran out, but in October 2002 her true cause of death was reported as stress and overheating on the fourth orbit due to failure of the air conditioning system. At a Moscow press conference in 1998 Oleg Gazenko, a senior Soviet scientist involved in the project, stated "The more time passes, the more I'm sorry about it. We did not learn enough from the mission to justify the death of the dog...".
After independence in 1947, Jinnah, the president of the Muslim League, became Pakistan's first governor-general and the first President-Speaker of the Parliament, but he died of tuberculosis on 11 September 1948. Meanwhile, Pakistan's founding fathers agreed to appoint Liaquat Ali Khan, the secretary-general of the party, the nation's first prime minister. From 1947 to 1956, Pakistan was a monarchy within the Commonwealth of Nations, and had two monarchs before it became a republic. The creation of Pakistan was never fully accepted by many British leaders, including Lord Mountbatten. Mountbatten expressed his lack of support and faith in the Muslim League's idea of Pakistan. Jinnah refused Mountbatten's offer to serve as Governor-General of Pakistan. When Mountbatten was asked by Collins and Lapierre if he would have sabotaged Pakistan had he known that Jinnah was dying of tuberculosis, he replied 'most probably'.
However, at least one court case has resulted in a product being taken off the market. In December 2010, the United States Food and Drug Administration (FDA) issued a warning to consumers about such products stating, "The FDA has found many products marketed as dietary supplements for sexual enhancement during the past several years that can be harmful because they contain active ingredients in FDA-approved drugs or variations of these ingredients."
Sources: en.wikipedia.org
=== In medicine and medical research === Purified lectins are important in a clinical setting because they are used for blood typing. Some of the glycolipids and glycoproteins on an individual's red blood cells can be identified by lectins.
Between 1978 and 1979 Channon designed and fabricated an insulin pump driven by a small compression spring with a programmable bore to allow different rates of insulin infusion. Channon tested this device on himself in what is believed to be the first time a background bolus regime was used to treat an insulin dependent diabetic. The device is now part of the Bristol Museums Collection. With the support of two National Medical Research fund (now WellChild) grants - £26,000 to Channon to fund his secondment and £40,000 to Guy's to support the clinical evaluation - Channon developed a compact insulin infusion pump "no larger than a pocket cigarette lighter" and weighing just three ounces. The pump could be set to a 3-stage decaying programme, which automatically delivered 3 infusions during the day with a successively lower dose on the 2nd and 3rd. In addition the user could manually operate the device when required to cope with the additional insulin required when eating a meal. Channon's work received national, regional and professional coverage including articles in the Times, the Telegraph, New Scientist and the bulletin of the Institute of Marine Engineers. In 1981 the work was featured in the national magazine of Diabetes UK. Following a suggestion by Professor Keen, Channon also developed a 5ml syringe with a precision engineered mechanism for delivering doses of insulin with an audible and tactile click on each rotation of a knurled thimble, for use by blind and deaf-blind diabetics.
===== Finasteride ===== Finasteride is used to treat male pattern hair loss. Treatment provides about 30% improvement in hair loss after six months of treatment, and effectiveness only persists as long as the drug is taken. There is no good evidence for its use in women. It may cause gynecomastia, erectile dysfunction and depression.
The educational experience of many Colombian children begins with attendance at a preschool academy until age five (Educación preescolar). Basic education (Educación básica) is compulsory by law. It has two stages: Primary basic education (Educación básica primaria) which goes from first to fifth grade – children from six to ten years old, and Secondary basic education (Educación básica secundaria), which goes from sixth to ninth grade. Basic education is followed by Middle vocational education (Educación media vocacional) that comprises the tenth and eleventh grades. It may have different vocational training modalities or specialties (academic, technical, business, and so on.) according to the curriculum adopted by each school.
=== Litigation by the company against the NHS === In 2018, AbbVie sued NHS England in the Technology and Construction Court claiming that the agency breached procurement rules and had not treated the company fairly when seeking suppliers for hepatitis C treatments. In 2019, a UK court dismissed AbbVie's case against the NHS.
Sources: en.wikipedia.org
The People's Movement of Serbia (Serbian: Народни покрет Србије, romanised: Narodni pokret Srbije, abbr. NPS) is a centre-right political party in Serbia. Miroslav Aleksić has been the party's president since its reformation in August 2023. NPS previously existed from 2014 to 2017 and was also led by Aleksić, who was its only member in the National Assembly of Serbia. In October 2017, Aleksić allowed the party to be re-registered as the People's Party under the leadership of Vuk Jeremić.
== Clinical relevance == Using MFAP4-deficient mouse models, studies have shown roles for MFAP4 in neointima formation and asthma. Moreover, it has recently been shown that the glycosylation of MFAP4 is raised in the aortic extracellular matrix of Marfan syndrome patients using proteomics and gene expression levels of MFAP4 correlate with alterations in extracellular matrix genes within human aortic vascular smooth muscle cells.
Inframammary incision: The plastic surgeon makes a long cut at the inframammary fold (IMF) — the bottom border of the breast — for maximal access to the interior of the breast hemisphere. The inframammary incision allows for the precise cutting of tissues in order to securely emplace the prosthetic breast into the implant-pocket cut into the chest muscle. Moreover, according to the skin-type of the woman, the emplacement of a prosthetic breast by way of an IMF-incision can result in noticeable surgical scars. Periareolar incision: The surgeon makes a short incision (5.0 cm.) along the areolar periphery (outside border of the areola) which allows for the symmetrical adjustment of the position of the inframammary fold (IMF) of the augmented breast. The periareolar incision is made at the medial-half (bottom half) of the outside border of the nipple-areola complex (NAC) of the breast to be augmented. Given the narrow access allowed into the skin-envelope of the breast hemisphere, the short, five-centimetre length of the periareolar incision makes difficult the surgeon's emplacement of a voluminous breast-implant made of silicone gel. Moreover, as a surgical approach, the periareolar incision (cutting along the outside border of the NAC) allows the plastic surgeon to also do a breast-lift procedure that has been included to an initial, primary mammoplasty procedure.
=== Media and arts representation of sickle cell disease === Popular media and art have been important educational tools about sickle cell disease. Hertz Nazaire was a Haitian-American visual artist, writer, and advocate who lived with sickle cell disease and used his art to raise awareness, combat stigma, and champion better access to care. Representations of sickle cell disease in television shows include in the longrunning American medical drama ER (season 4 "Obstruction of Justice" and season 15 "Separation Anxiety" and "Dream Runner"), the 2024 British superhero series Supacell, in the 2024 period drama Lady in the Lake, and in the 2025 medical procedural drama The Pitt (episode "8:00 am"). Noah Wyle, who plays Dr. Michael "Robby" Robinavitch on The Pitt, has spoken about the importance of popular media representation of sickle cell and the impacts of racism on the quality of care patients receive. Sickle cell disease has also been featured in several movies including the 1973 Sydney Poitier classic, A Warm December, 1996 Nigerian drama Mortal Inheritance, Genie Award- winning 2008 Canadian drama Nurse.Fighter.Boy, the 2017 animated documentary Spilled Milk, the 2020 Nigerian drama Strain, the 2022 animated short The Park Bench, and the 2023 American sci-fi action film Transformers: Rise of the Beasts.
Sources: en.wikipedia.org
Purity is commonly estimated by reversed-phase high-performance liquid chromatography with ultraviolet detection. Mass spectrometry is used to confirm identity and to detect sequence-related impurities. Reported percentages depend on the method and the impurity threshold used.
Lyophilized powder is usually kept frozen, desiccated, and protected from light. Reconstituted solutions are often divided into aliquots and stored at very low temperature to limit freeze-thaw cycles. Specific conditions should follow the supplier's certificate of analysis and the assay requirements.
Much of the evidence comes from animal models and cell-based assays rather than large human trials. Small sample sizes, short follow-up, and differences in dosing or route make comparisons difficult. Questions about long-term effects and human relevance remain open.
It is a synthetic pentapeptide belonging to the growth hormone secretagogue family. Its principal characterized target is the ghrelin receptor, also called GHS-R1a. The molecule contains non-natural amino acids and an amidated C-terminus.